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Highlights
 Sympathetic nerve activity is modulated by an interaction between central nervous 
system respiratory and sympathetic networks that leads to the generation of bursts of 
sympathetic nerve activity in phase with the respiratory cycle, termed respiratory-
sympathetic coupling.
 In disease states altered respiratory sympathetic coupling may drive the development 
and/or maintenance of sympatho-excitation, and in turn hypertension, as is seen in 
chronic kidney disease. 
 Using a rat model of chronic kidney disease, we showed in both young and adult 
animals the presence of enhanced respiratory-sympathetic coupling and an 
exaggerated sympathoexcitatory response to stimulation of the peripheral 
chemoreceptors with sodium cyanide (NaCN) and hypoxia, respectively. 
 These results indicate that the pathways responsible for respiratory-sympathetic 
coupling, may be potential therapeutic targets to reduce high blood pressure in 
association with chronic kidney disease.
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2Abstract
Respiratory modulation of sympathetic nerve activity (respSNA) was studied in a 
hypertensive rodent model of chronic kidney disease (CKD) using Lewis Polycystic 
Kidney (LPK) rats and Lewis controls. In adult animals under in vivo anaesthetised 
conditions (n=8-10/strain), respiratory modulation of splanchnic and renal nerve activity 
was compared under control conditions, and during peripheral (hypoxia), and central, 
chemoreceptor (hypercapnia) challenge.  RespSNA was increased in the LPK vs. Lewis 
(area under curve (AUC) splanchnic and renal: 8.71.1 vs. 3.50.5 and 10.61.1 vs. 
7.10.2 µV.s, respectively, P<0.05). Hypoxia and hypercapnia increased respSNA in 
both strains but the magnitude of the response was greater in  LPK, particularly in 
response to hypoxia. In juvenile animals studied using a working heart brainstem 
preparation (n=7-10/strain), increased respSNA was evident in the LPK (thoracic SNA, 
AUC: 0.86±0.1 vs. 0.42±0.1 µV.s, P<0.05), and activation of peripheral 
chemoreceptors (NaCN) again drove a larger increase in respSNA in the LPK with no 
difference in the response to hypercapnia. Amplified respSNA occurs in CKD and may 
contribute to the development of hypertension. 
Keywords
Respiratory sympathetic coupling, peripheral chemoreceptors, hypertension, chronic 
kidney disease, working heart brainstem preparation.
31. Introduction
Hypertension is a major comorbidity associated with chronic kidney disease (CKD), 
arising early in the development of CKD and acting as a significant causal factor for the 
development of end-organ damage (Vanholder et al., 2005). Increased sympathetic 
nerve activity (SNA) is believed to play an important role in the development and/or 
maintenance of hypertension associated with kidney disease, with direct sympathetic 
nerve recording and plasma catecholamines levels elevated in individuals with CKD 
(Campese et al., 2011; Grassi et al., 2012; Klein IH, 2003; Phillips, 2005; Schlaich et 
al., 2009). Treatment with centrally acting sympatholytic agents can ameliorate 
hypertension in renal failure patients (Campese and Massry, 1983; Levitan et al., 1984; 
Schlaich et al., 2009), however, we still do not understand the mechanisms driving this 
increase in SNA.
Modulation of sympathetic nerve discharge occurs during the phases of respiration both 
in animals and humans, although the temporal relationship can differ between species 
and different nerve beds (Boczek-Funcke et al., 1992; Seals et al., 1993; Simms et al., 
2009; Zoccal et al., 2008). This respiratory modulation of SNA (respSNA) creates 
synchronous alterations in blood pressure that allow optimal tissue perfusion. In 
experimental animals, where open-chest experiments have been performed, a 
component of the respSNA involves coupling between the relevant neuronal circuits 
within the brainstem (Machado et al., 2017; Simms et al., 2010). In the spontaneously 
hypertensive rat (SHR), a model of essential hypertension, respSNA is augmented and 
when compared to normotensive Wistar Kyoto control rats, the phase relationship is 
shifted from the post-inspiratory to inspiratory phase (Czyzyk-Krzeska and Trzebski, 
1990; Simms et al., 2009). This exaggerated respSNA contributes to the development of 
4hypertension in the SHR (Menuet et al., 2017). In CKD it is not known whether the 
phasic pattern of respSNA is altered or whether it contributes to the observed increase 
in SNA and the  associated hypertensive state (Augustyniak et al., 2002; Salman et al., 
2015). 
The respSNA originating from central connections of respiratory and sympathetic 
networks (Haselton and Guyenet, 1989; Koshiya and Guyenet, 1996; Spyer, 1993; Sun 
et al., 1997) contributes independently to increased SNA in animal models following 
chronic intermittent hypoxia (Zoccal et al., 2008), with evidence of input from excitable 
central chemoreceptors (Molkov et al., 2011). The peripheral chemoreceptors may also 
provide a critical respiratory-related input that contributes to respSNA and, in disease 
states, drives the development and/or maintenance of sympatho-excitation, and in turn 
hypertension. This hypothesis is supported by a large body of work showing that 
exposure to chronic intermittent hypoxia (CIH) is correlated with enhanced respSNA 
(Machado et al., 2017). Patients with CKD are more vulnerable to respiratory disorders 
such as obstructive sleep apnoea (Hanly, 2004), and those with sleep apnoea have 
elevated blood pressure compared to those with CKD alone (Sekizuka et al.). Further, 
deactivation of the peripheral chemoreceptors, with hyperoxia, reduces muscle SNA in 
individuals with renal failure (Hering et al., 2007). In this context, there is exciting 
therapeutic potential in the investigation of the role of central respSNA and its 
underlying mechanism in hypertension CKD.
The main purpose of this study, therefore, was to test the hypothesis that respSNA is 
amplified in an animal model of CKD. Studies were undertaken in the Lewis polycystic 
kidney (LPK) rat, a genetic model of CKD presenting with kidney disease (McCooke et 
5al., 2012) in which we have previously demonstrated hypertension, enhanced tonic SNA 
and perturbed reflex responses to both peripheral and central chemoreceptor stimulation 
(Salman et al., 2014; Salman et al., 2015; Yao et al., 2015). 
2. Methods
All experimental procedures were approved by the Animal Ethics Committees of 
Macquarie University, NSW or the University of Melbourne, Victoria, Australia, and 
were carried out in accordance with the Australian Code of Practice for the Care and 
Use of Animals for Scientific Purposes. 
2.1 Study 1: Adult in vivo anaesthetised experiments
Adult (12-13-week-old) male LPK (n = 8) and control Lewis (n = 10) rats were used. 
Animals were purchased from the Animal Resources Centre, Murdoch, Western 
Australia. 
2.1.1 Renal function
A 24 h urine sample was collected from all animals 48 h prior to experimentation and 
urine volume, urinary creatinine and protein levels examined using a IDEXX Vetlab 
analyser (IDEXX Laboratories Pty Ltd., Rydalmere, NSW, Australia). At the 
commencement of the surgical procedure, an arterial blood sample was collected for 
determination of plasma urea and creatinine, and creatinine clearance calculated as 
described previously (Yao et al., 2015). 
2.1.2 Surgical procedures:
Animals were anaesthetised with 10% (w/v) ethyl carbamate (Urethane, Sigma Aldrich, 
NSW, Australia) in 0.9% NaCl solution (1.3 g/kg i.p.). Reflex responses to hind-paw 
6pinch were assessed to determine adequate depth of anaesthesia and supplemental doses 
of ethyl carbamate given as required (65 mg/kg i.p. or i.v.). Body temperature was 
measured and maintained at 37 ± 0.5 C using a thermostatically controlled heating 
blanket (Harvard Apparatus, Holliston, MA, USA) and infrared heating lamp. The right 
femoral vein and artery were cannulated for administration of fluid (Ringer’s lactate, 5 
ml/kg/h) and measurement of arterial pressure (AP) and blood collection for 
measurement of blood gases, respectively. The AP signal was sampled at 200 Hz and 
acquired using a CED 1401 plus and Spike2 software v.7 (Cambridge Electronic 
Designs (CED) Ltd, Cambridge, UK, RRID:SCR_000903). A tracheostomy was 
performed and an endotracheal tube placed in situ. A bilateral vagotomy was performed 
to cut afferent inputs from the stretch receptors of the lung and the animal was 
ventilated with oxygen enriched room air (7025 Rodent Ventilator, UgoBasile, Italy) 
and paralysed with pancuronium bromide (2 mg/kg iv for induction, 1 mg/kg for 
maintenance as required; AstraZeneca, North Ryde, NSW, Australia). The left phrenic, 
splanchnic and renal nerves were dissected and the distal end of each nerve was tied and 
cut. All nerves were bathed in a liquid paraffin pool and activity was recorded from the 
central end using bipolar silver wire recording electrodes. The activity was 10 times 
amplified, band-pass filtered between 10-1000Hz by a bio amplifier (CWE Inc., 
Ardmore, PA, USA) and sampled at 5kHz using CED 1401 plus and Spike2 software. 
All recordings were made with the same bioamplifier calibrated to a pre-set setting 50 
µV. 
Following surgical preparation, animals were then stabilised for 30 min. Arterial blood 
samples were collected and analysed for pH, pCO2, HCO3-  and SaO2 using a VetStat 
Electrolyte and Blood Gas Analyser (IDEXX Laboratories Pty Ltd., Rydalmere, NSW, 
7Australia).  After the initial blood gas measurement, arterial blood gases were then 
corrected by adjusting the ventilator pump rate and volume and/or slow bolus injections 
of 5% sodium bicarbonate as required to maintain parameters under control conditions 
within the following range: pH = 7.4 ± 0.5; PCO2 = 40 ± 5 mmHg; HCO3- = 24 ± 2 
mmol/L, SaO2 = 100%; and end tidal (ET)CO2 = 4.5 ± 0.5%. Repeat blood gas analysis 
was undertaken as required. 
2.1.3 Experimental protocol
After the period of stabilization, the integrity of renal and splanchnic nerve recordings 
(rSNA and sSNA respectively) was confirmed by pulse modulation of SNA and 
demonstration of a baroreflex response to a bolus injection of phenylephrine (50 µg/kg 
iv, Sigma-Aldrich, St. Louis, MO, USA). Baseline parameters were measured under 
control conditions for a period of 30 min. Pilot studies indicated that hypoxic 
stimulation to stimulate the peripheral chemoreceptors using 10% O2 in N2 (Abbott and 
Pilowsky, 2009) could not be used for the 3 min stimulation period without affecting 
pH and PCO2 in the LPK, and therefore animals were ventilated with room air, without 
oxygen supplementation, for a period of 3 min without any change in ventilator rate or 
volume. This induced a stable modest hypoxia - blood gas analysis  parameters in the 
range of pH = 7.4 ± 0.5; PCO2 = 43 ± 3 mmHg; HCO3- = 24 ± 2 mmol/L and SaO2 = 
82-84%. After a 30 min recovery period, central chemoreceptor stimulation was 
performed by ventilating the animals with 5% carbogen (5% CO2 in 95% O2) for 3 min 
without any change in the ventilator rate or volume, which was confirmed by blood gas 
analysis to produce hypercapnia with parameters in the range of pH = 7.4 ± 0.5; PCO2 = 
62 ± 7 mmHg; HCO3- = 24 ± 2 mmol/L and SaO2 =100%. 
8At the end of experiment, all animals were euthanized with potassium chloride (3M i.v.) 
and the electrical noise levels for phrenic nerve activity (PNA), sSNA and rSNA 
recorded and later subtracted for data analysis.
2.1.4 Data analysis
All data were analysed offline using Spike 2 software. From the AP signal, mean 
(MAP), systolic blood pressure (SBP), diastolic (DBP) and pulse (PP) pressure and 
heart rate (HR) were derived. The sSNA and rSNA were rectified and smoothed with a 
time constant of 0.1 s and PNA was rectified and smoothed with a time constant of 0.05 
s. Baseline data was determined from a 30 s period at the end of the control ventilation 
period. Response to respiratory challenge was analysed over a 30 s period once PNA 
had stabilised for a period of 1-2 min and expressed as a change (∆) relative to the 30 s 
period immediately prior to each stimulus. The PNA amplitude, frequency (number 
cycle.min -1), duration (s) and minute activity (MPA=PNA amplitude x PNA frequency) 
were measured to quantify the changes. The phrenic cycle was divided into three 
phases: inspiratory (I), post-inspiratory (PI) and expiratory (E). For SNA, the mean 
level was measured from the period 200 ms prior to the onset of the phrenic burst, and 
this was considered the baseline for all other measurements. A phrenic-triggered 
average of the rectified and smoothed sSNA and rSNA recordings was performed and 
the phases divided into I, PI, and E. From this trace the following parameters were 
calculated for sSNA and rSNA: the peak amplitude (PA [V]), the maximum amplitude 
at the apex of the peak of the SNA burst coincident with inspiratory/post-inspiratory 
phase, the duration (from onset of excitatory activity to return to baseline [s]) and area 
under curve (AUC) of respSNA excitatory peak (V.s) determined as the integral of the 
9waveform. AUC of respSNA for I, PI and E phase of phrenic cycle were also calculated 
from the integral of the waveform. 
2.2. Study 2: Juvenile working heart brainstem preparation
To determine respSNA in early stages of the disease process, another series of 
experiments were performed in juvenile rats using the working heart brainstem in-situ 
preparation, which while a reduced preparation has the advantage of allowing 
assessment of physiological patterns of central respiratory control and cardiovascular 
regulation in the absence of the effects of anaesthesia (Wilson et al., 2001). Recordings 
were made in 5 week old male Lewis (n = 7) and LPK (n = 10) as described previously 
(Menuet et al., 2014). At this age, renal function is only mildly impaired in the LPK 
(Phillips et al., 2007). Animals were purchased from the Animal Resources Centre, 
Murdoch, Western Australia. 
2.2.1 Surgical procedure
Animals were deeply anaesthetized with isoflurane until loss of the pedal withdrawal 
reflex and then dissected below the diaphragm, exsanguinated, cooled in Ringer 
solution on ice (composition in mM: 125 NaCl, 24 NaHCO3, 5 KCl, 2.5 CaCl2, 1.25 
MgSO4, 1.25 KH2PO4 and 10 dextrose, pH 7.3 after saturation with carbogen gas (5% 
CO2, 95% O2) and decerebrated precollicularly. Lungs were removed and the 
descending aorta isolated and cleaned. Retrograde perfusion of the thorax and head was 
achieved via a double-lumen catheter (ø 1.25 mm, DLR-4, Braintree Scientific, 
Braintree, MA, USA) inserted into the descending aorta. The perfusate was Ringer 
solution containing Ficoll (1.25%) warmed to 31C and gassed with carbogen (95% O2 
and 5% CO2; closed loop reperfusion circuit). The second lumen of the cannula was 
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connected to a transducer to monitor perfusion pressure in the aorta. Neuro-muscular 
blockade was achieved using vecuronium bromide added to the perfusate (2–4 μg/mL, 
Organon Teknika, Cambridge, UK). Simultaneous recordings of PNA, thoracic 
sympathetic nerve activity (tSNA, T8-10), vagus nerve activity (VNA) and abdominal 
nerve activity (AbNA, T9-T12) were obtained using glass suction electrodes. The 
activity was amplified (10 kHz, Neurolog), filtered (50–1500 kHz, Neurolog), digitized 
(CED) and recorded using Spike2 (CED). 
2.2.2 Experimental protocol
After the period of stabilization, the peripheral chemoreceptors were stimulated using 
sodium cyanide (NaCN; 0.05%; 100 µL bolus) injected into the aorta via the perfusion 
catheter (Chang et al., 2015; Menuet et al., 2016). Central chemoreceptors were 
stimulated using hypercapnic conditions by changing the level of CO2 in the perfusate 
source from 95% O2 and 5% CO2 to 90% O2 and 10% CO2 for ~5 min. The electrical 
noise levels for tSNA recordings were determined at the end of experiments by 
sectioning the sympathetic chain at the proximal paravertebral ganglion level and were 
subtracted for data analysis. All chemicals were purchased from Sigma-Aldrich, 
Australia.
2.2.3 Data analysis
All data were analysed offline using Spike 2 software. The signals were rectified and 
integrated with a 50 ms time constant. The HR was derived using a window 
discriminator to trigger from the R-wave of the electrocardiogram recorded 
simultaneously with PNA. The PNA, and VNA signals were used to assess respiratory 
parameters associated with inspiration, post-inspiration and expiration, respectively. 
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During baseline and hypercapnic conditions, phrenic-triggered (end of inspiratory burst) 
averaging of tSNA was used for the analysis of tSNA parameters related to the burst of 
respSNA tSNA and tonic non-respiratory modulated tSNA (baseline tSNA). NaCN-
induced respSNA was measured as delta increase in AUC compared to a pre-stimulus 
control period with same duration (Menuet et al., 2016), while peak activity of respSNA 
of tSNA was calculated as the maximum amplitude of the tSNA burst coincident with 
inspiratory/post-inspiratory transition. 
2.3 Statistical analysis
All data are presented as mean ± SEM. A Student's t-test was used to determine baseline 
differences in cardiorespiratory function and respiratory sympathetic coupling between 
the LPK and Lewis. A two-way ANOVA with repeated measures followed by 
Bonferroni's post-hoc analysis was used to analyse the effect of peripheral or central 
chemoreceptor challenge on respiratory sympathetic coupling with strain and 
chemoreceptor challenge as the variables. All analysis was performed using GraphPad 
Prism software v6.0 (GraphPad Software Inc., La Jolla, California, USA, 
RRID:SCR_002798). Differences were considered statistically significant where 
P<0.05. 
3. Results 
3.1 Adult baseline parameters
Adult male LPK rats showed a phenotypic elevation in blood urea (24.3 ± 2.3 vs. 5.9 ± 
0.3 mmol/L) and plasma creatinine (60.6 ± 11.7 vs. 22.3 ± 4.6 µmol/L) and reduction in 
creatinine clearance (2.08 ± 0.4 vs. 10.1 ± 2.3 mL/min) (all LPK n=8 vs. Lewis n=10; 
P< 0.001) reflective of impaired renal function. 
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During the control period, individual recordings were made of rSNA, sSNA, PNA and 
AP from Lewis and LPK rats (Figure 1). Consistent with our previous work (Salman et 
al., 2014; Yao et al., 2015), SBP, MAP, DBP, PP, HR and SNA (both sSNA and rSNA) 
were elevated in the adult LPK compared with age-matched Lewis controls (Table 1). 
Phrenic frequency was also significantly higher in the adult LPK, suggestive of 
increased central respiratory drive; however, there was no significant difference in PNA 
amplitude or MPA between strains (Table 1). 
We examined the temporal relationship between SNA and the respiratory cycle in LPK 
and Lewis rats under control conditions. Both the rSNA and sSNA exhibited distinct 
respSNA, with a clear burst in SNA in the PI period in both the Lewis and LPK (see 
Figures 2 and 4, control panels A -B [renal], E-F [splanchnic]). In the Lewis rat, both 
sSNA and rSNA showed a tendency to increase from baseline during I, before the sharp 
peak occurred in PI. After the PI peak, activity fell quickly to baseline and was 
relatively flat during E. The LPK showed a distinct difference – with a decrease in 
activity below baseline during early I that was most obvious in rSNA (rSNA, I phase 
AUC, LPK vs Lewis: -0.07 ± 0.03 vs 0.45 ± 0.2; P ≤ 0.5; sSNA, I phase AUC, LPK vs 
Lewis: 0.06 ± 0.05 vs 0.18 ± 0.08 ; P > 0.5). There was a gradual decline in both sSNA 
and rSNA during the E period which was not significantly different between the strains 
(rSNA, E phase AUC, LPK vs Lewis: 0.07 ± 0.04 vs 0.08 ± 0.1; P > 0.5; sSNA, E 
phase AUC, LPK vs Lewis: 0.02 ± 0.03 vs 0.04 ± 0.02; P > 0.5 [Figures 2 and 4, 
control panels A -B (renal), E-F (splanchnic)].
Quantitative parameters characterizing respSNA under control conditions for both 
nerves are provided in Table 2. PA and AUC for both sSNA and rSNA were 
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significantly greater in the LPK compared with Lewis. The duration of the respSNA for 
both sSNA and rSNA was not different between the Lewis and LPK indicating that the 
greater AUC observed in the LPK was driven primarily by the greater PA.
3.2 Adult responses to chemoreceptor stimulation 
In response to a hypoxic challenge, a greater increase in AP was observed in the LPK 
compared with Lewis (Table 3). In the LPK rat this was associated with a slight, but 
significant, slowing of PNA frequency, but not amplitude or duration. The hypercapnic 
challenge produced comparable increases in AP and central respiratory drive in the two 
strains, with only a small difference in the HR response. 
In both strains, under hypoxic and hypercapnic conditions, the respSNA curves of 
sSNA and rSNA retained a consistent PI peak (see Figures 2 and 4). In response to 
hypoxia, respSNA (sSNA and rSNA) was increased in both strains as reflected by an 
increase in PA in Lewis and an increase in PA and AUC in LPK (Figure 3) that was 
greater in LPK rats (delta AUC, sSNA: Lewis vs. LPK: 0.8 ± 0.6 vs. 5.9 ± 1.9, rSNA: 
2.8 ± 0.7 vs. 7.5 ± 2.1 µV.s, both P< 0.05). Hypercapnia induced an increase in the 
respSNA of sSNA as reflected by an increase in PA in Lewis and an increase in PA and 
AUC in LPK. In the rSNA there was an increase in PA in the Lewis only (Figures 4, 5). 
However, the magnitude of the change in the respSNA of both nerves was similar 
between strains (Delta AUC, sSNA, Lewis vs. LPK: 1 ± 0.4 vs. 2.5 ± 0.7; rSNA, Lewis 
vs. LPK: 3.2 ± 0.5 vs. 2.5 ± 1.4 µV.s, both P > 0.05). During hypoxia, the inspiratory 
inhibition in the LPK increased in rSNA (I phase AUC, rSNA, control vs. hypoxia: -
0.07 ± 0.04 vs. -0.9 ± 0.3 µV.s p < 0.05; Figure 2) and became clearly evident in sSNA 
(I phase AUC, sSNA, control vs. hypoxia : 0.05 ± 0.04 vs. -0.4 ± 0.1 µV.s P < 0.05). 
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This increase in inspiratory inhibition did not occur in the LPK under hypercapnic 
conditions ( I phase AUC, rSNA, control vs. hypercapnia : -0.32 ± 0.2 vs. -0.4 ± 0.2 
sSNA: 0.03 ± 0.09 vs. 0.06 ± 0.1 µV.s both P >0.05). There was no significant change 
to the inspiratory phase in the Lewis animals under either condition. 
3.3 Juvenile baseline parameters
In the working heart brainstem preparation (Figure 6), mean perfusion pressure was not 
different between the two strains (Lewis vs. LPK: 73 ± 4 vs. 76 ± 2 mmHg, P = 0.55). 
The HR was faster in the LPK (Lewis vs. LPK: 360 ± 13 vs. 302 ± 17 bpm, P < 0.05). 
There was no difference observed in PNA frequency (Lewis vs. LPK: 9.5 ± 0.7 vs. 10.2 
± 1.6, P = 0.74), although inspiratory duration of PNA was reduced in the LPK (Lewis 
vs. LPK: 1658 ± 147 vs. 1242 ± 79 ms, P < 0.05). Tonic levels of tSNA were not 
significantly different (Lewis vs. LPK: 4.37 ± 0.47 vs. 4.51 ± 0.58 µV, P = 0.85); 
however, respiratory modulation of tSNA was greater in the LPK with a larger AUC 
observed (Lewis vs. LPK: 0.42 ± 0.13 vs. 0.86 ± 0.13 µV.s, P < 0.05). No differences 
were observed in respSNA burst duration (Lewis vs. LPK: 0.8 ± 0.1 vs. 1.4 ± 0.2 s, P = 
0.10) or the magnitude of the peak amplitude of tSNA (Lewis vs. LPK: 6.01 ± 0.56 vs. 
6.17 ± 0.85 µV, P = 0.87). 
3.4 Juvenile responses to chemoreceptor stimulation
Peripheral chemoreceptor activation with NaCN produced a comparable increase in 
perfusion pressure in both strains (Lewis vs. LPK: 5.7 ± 1.4 vs. 6.4 ± 1.2 mmHg, P = 
0.71). The accompanying large bradycardia was of greater magnitude in the LPK 
(Lewis vs. LPK: -86 ± 18 vs. -176 ± 16 bpm, P < 0.05). RespSNA increased in both 
strains in response to peripheral chemoreceptor activation (NaCN, P<0.05; Figure 6), as 
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evidenced by an increase in PA and AUC that was of greater magnitude in both 
circumstances in the LPK. (Lewis vs. LPK: delta PA: 3.6 ± 0.6 vs. 6.5 ± 0.9 µV, delta 
AUC: Lewis vs. LPK: 7.0 ± 1.2 vs. 15.1 ± 2.7 µV.s, P<0.05).
Central chemoreceptor activation with hypercapnia produced a comparable reduction in 
perfusion pressure (Lewis vs. LPK: -7.9 ± 1.9 vs. -8.6 ± 1.1 mmHg, P = 0.75) and HR 
(Lewis vs. LPK: -42 ± 9 vs. -53 ± 8 bpm, P = 0.36) in the two strains. RespSNA 
increased in both strains (Figure 7) with an increase in PA in the LPK and a comparable 
increase in AUC in both strains (delta AUC: 0.98 ± 0.16 vs. 0.99 ± 0.29 µV.s, P = 
0.97). 
4. Discussion
Our study has determined the characteristic features of respSNA in a rodent model of 
CKD. We have directly measured the relationship between inspiratory drive and two 
sympathetic nerves in anaesthetized adult animals and to one sympathetic nerve in 
juvenile animals using the working heart brainstem preparation. The timing of the peak 
of respSNA was observed persistently in the PI period under all conditions tested and, 
from the earliest age studied (5 weeks). Adult and juvenile LPK rats demonstrated 
increased respSNA compared to Lewis control rats. Under control conditions,  the LPK 
rat shows an alteration in respSNA patterning with increased inhibition of rSNA during 
the inspiratory period. This inspiratory inhibition is augmented in rSNA with hypoxia 
and becomes evident in sSNA with this respiratory challenge. In addition, we have 
found that peripheral chemoreceptor stimulation has an exaggerated effect on respSNA 
in both the juvenile and adult LPK animals, which suggests a role for peripheral 
chemoreceptors in the pathophysiology of autonomic dysfunction associated with CKD. 
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Our finding of augmented respSNA in the LPK model of CKD is consistent with 
previous work in the SHR model, which also demonstrates amplified respSNA when 
examined using the same methodologies in juvenile (Menuet et al., 2017; Simms et al., 
2009) and adult SHRs (Czyzyk-Krzeska and Trzebski, 1990) that we have applied, 
though notably, we do not see the marked temporal shift in the peak response from post-
inspiration to inspiration that is described in the SHR during the development of 
hypertension. Enhancement of respSNA is also a feature noted in animal models of 
chronic intermittent hypoxia (Zoccal et al., 2008), congestive heart failure (Marcus et 
al., 2014); and in rats following uteroplacental insufficiency (Menuet et al., 2016). 
Common to these diseases is autonomic dysfunction and the development of 
hypertension in association with increased SNA. 
While we did not see elevated baseline tSNA or perfusion pressures in the juvenile LPK 
at 5 weeks of age, our previous work in both young and adult LPK (7 and 14 weeks) 
show increased SNA, including recordings from conscious animals (Salman et al., 
2014; Salman et al., 2015), and we observe markedly elevated blood pressure in these 
animals from an early age (6 weeks) (Phillips et al., 2007; Sarma et al., 2012). Our 
demonstration of increased respSNA at age 5 weeks in the current study indicates that 
altered sympathetic activity is a key feature of the autonomic dysfunction in the LPK 
model, consistent with clinical data demonstrating that in patients with polycystic 
kidney disease, muscle SNA is elevated very early in the disease, often prior to any 
significant reduction in renal function (Klein et al., 2001). Our work is supportive of the 
hypothesis that in CKD, altered interactions between central respiratory and 
sympathetic pathways is a contributor to the development and maintenance of 
hypertension. 
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The rostral ventrolateral medulla (RVLM) is an important site in the generation and 
regulation of sympathetic vasomotor tone (Guyenet, 2006), and our recent work in the 
SHR suggests that the inspiratory pre-Bötzinger complex is a likely site of modulatory 
inputs to the RVLM C1 neurons which could drive an increase in SNA (Menuet et al., 
2017). There is also an important contribution from the respiratory pattern generator 
that results in phasic modulation of RVLM presympathetic neurons.  Recordings from 
both anesthetised rats and juvenile rats using the working heart brainstem preparation 
show 3 main classes of respiratory-modulated RVLM presympathetic neurons – I 
activated, PI activated and I inhibited – as well as some none modulated neurons 
(Haselton and Guyenet, 1989; Moraes et al., 2013).  Whilst not directly tested in this 
study, we propose that altered strength of respiratory input to these different neuron 
classes could underlie the different patterns of respSNA observed including the 
enhanced I inhibition of respSNA in the LPK rat.
While the exact mechanisms underlying amplified respSNA have not yet been 
elucidated, it has been suggested that interaction between central (Molkov et al., 2011) 
and peripheral chemoreceptor pathways (Guyenet et al., 2009; Moraes et al., 2015) may 
contribute to increased sensitivity of retrotrapezoid nucleus (RTN). The RTN has been 
shown to play a critical role in amplified respSNA under conditions of chronic 
intermittent or sustained hypoxia (Molkov et al., 2014; Moraes et al., 2014). Of 
relevance to our work is that peripheral chemoreceptor hypersensitivity has been 
suggested to contribute to the development of sympathetic over activity in kidney 
disease (Hering et al., 2007). In the current study, stimulation of peripheral 
chemoreceptors by NaCN and hypoxia evoked an increase in respSNA parameters in 
both the juvenile and adult animals, respectively, that was of a significantly greater 
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magnitude in the LPK. In contrast, exposure to hypercapnia, which drives a centrally 
mediated chemoreflex and subsequent sympathoexcitatory and pressor response, 
produced changes which were similar between the strains. Moreover, adult LPK rats 
showed a higher respSNA even in control condition, and inspiratory motor activity was 
similar between strains after both peripheral and central chemoreceptor stimulation. 
Given the evidence that chronic intermittent hypoxia induces sensitization of peripheral 
chemoreceptors, producing an exaggerated sympathoexcitation and increased 
expiratory-related SNA (Braga et al., 2006; Moraes et al., 2012; Zoccal et al., 2008), 
and that increased peripheral chemoreceptor sensitivity contributes to sympathetic over 
activity and hypertension in SHR rats (Paton et al., 2013b; Tan et al., 2010), we 
speculate that there may be at least two mechanisms working centrally in the medulla 
oblongata to contribute the augmented respSNA seen in association with hypertension 
in CKD; one dependent on peripheral chemoreceptors and another one that is 
independent. 
Hypoxia is a common contributing factor for amplified respSNA and increased SNA in 
disease conditions including hypertension (Calbet, 2003; Somers et al., 1988; Zoccal et 
al., 2008), and while we did not investigate directly the mechanism behind increased 
respSNA in CKD in the present study, of relevance is our previous published data that 
has documented vascular remodelling, hypertrophic changes and calcification in the 
aortic arch of LPK animals (Salman et al., 2014). This type of vascular remodelling is 
closely associated with ageing, hypertension and CKD in humans and is documented to 
occur in the carotid/vertebral arteries, and in association with atherosclerosis, can result 
in increased intima-media thickness and ultimately narrowing the lumen of the carotid 
and vertebral artery (Tanaka et al., 2012; Yamada et al., 2014). Given that the carotid 
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body and brainstem are highly vascular organs and peripheral/central chemoreceptors 
are sensitive to reduced blood flow, remodelling of the carotid body/cerebral arterioles 
could be a persistent stimulus for central/peripheral chemoreceptor hypersensitivity 
(Moraes et al., 2014; Paton et al., 2013a). Anaemia is also common in CKD, a feature 
well documented in the LPK strain (Phillips et al., 2015), which in itself may be cause 
of persistant hypoxia. Regardless of the mechanism, we presume that in CKD, a 
persistent hypoxic stimulus via peripheral chemoreceptor independent and/or dependent 
pathways, can drive premotor sympathetic neurons and respiratory (expiratory) neurons 
to produce amplified respSNA and increased sympathetic tone in similar way to that of 
other pathological conditions (Wong-Riley et al., 2013; Zoccal and Machado, 2010; 
Zoccal et al., 2008). 
In conclusion, we provide evidence that respSNA is augmented and associated with 
increased SNA and hypertension in CKD. We further demonstrate an exaggerated 
respSNA response to peripheral chemoreceptor stimulation, indicating this modulatory 
pathway may act as one of the drivering factors of autonomic dysfunction in CKD. The 
pathways responsible for modulation of respSNA, from the carotid body 
chemoreceptors to central sites such as the RVLM, may well be valuable novel 
therapeutic targets in CKD. Our data also show that changes in respSNA are evident 
very early in the disease process, suggesting that early intervention may help to reduce 
the complex pathogenesis of CKD.
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Tables
Table 1: Baseline cardiorespiratory function in adult Lewis and LPK rats
Lewis LPK
MAP (mmHg) 90 ± 4 125 ± 10*
SBP (mmHg) 117 ± 8 194 ± 22*
DBP (mmHg) 75 ± 3 99 ± 10*
PP (mmHg) 41 ± 6 87 ± 18*
HR (bpm) 453 ± 9 480 ± 3*
PNA amplitude (µV) 18.3 ± 2.1 24.9 ± 5.3
PNA frequency 
(cycles/min)
36 ± 1 45 ± 1*
PNA duration (s) 0.82 ± 0.1 0.72 ± 0.01
MPA 674.9 ± 86.03 1125 ± 232
sSNA (µV) 3.1 ± 0.5 7.9 ± 1.3*
rSNA (µV) 5.2 ± 0.4 8.9 ± 0.6*
Measures of cardiorespiratory function in Lewis and LPK rats under control conditions. 
MAP: mean arterial pressure, SBP: systolic blood pressure, DBP: diastolic blood 
pressure, PP: pulse pressure, HR: heart rate, bpm: beats per min, PNA: phrenic nerve 
30
amplitude, MPA: minute phrenic activity, rSNA: renal sympathetic nerve activity, 
sSNA: splanchnic sympathetic nerve activity. Results are expressed as mean ± SEM. 
*P<0.05 between the Lewis and LPK as determined by Student’s t-test. n = 9 Lewis 
and n = 8 LPK excepting rSNA where n = 5 LPK and 6 Lewis
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Table 2: RespSNA parameters in splanchnic and renal sympathetic nerves under 
control conditions. 
Lewis LPK
splanchnic 4.1 ± 0.8 8.8 ± 1.1*
PA (V)
renal 8.7 ± 0.6 11.02 ± 0.8*
splanchnic 0.8 ± 0.07 0.99 ± 0.02Duration 
(sec) renal 0.8 ± 0.05 0.96 ± 0.05
splanchnic 3.5 ± 0.5 8.7 ± 1.1*
AUC (µV.s)
renal 7.1 ± 0.2 10.6 ± 1.1*
Measures of respSNA (phrenic triggered) parameters for integrated sSNA and rSNA in 
Lewis and LPK rats under control conditions. PA: peak amplitude, AUC: area under 
curve. Results are expressed as mean ± SEM. *P<0.05 between the Lewis and LPK as 
determined by Student’s t-test. sSNA data: n = 9 Lewis and n = 8 LPK, excepting rSNA 
where n = 5 LPK and 6 Lewis.
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Table 3: Effects of peripheral and central chemoreceptor stimulation on 
cardiorespiratory parameters in adult Lewis and Lewis Polycystic Kidney (LPK) rats
Lewis (n = 9) LPK (n = 8)
∆ MAP (mmHg) 4 ± 4 21 ± 5 *
∆ SBP (mmHg) 5 ± 5 34 ± 11 *
∆ DBP (mmHg) 4 ± 4 16 ± 4 
∆ PP (mmHg) 1 ± 2 18 ± 7 *
∆ HR (bpm) 12 ± 2 10 ± 1 
∆ PNA amplitude (µV) 10.9 ± 3.6 9.8 ± 3.9
∆ PNA duration (sec) 0.13 ± 0.02 0.07 ± 0.01
∆ PNA frequency (cycles/min) 5 ± 2 -2 ± 2*
Hypoxia
∆ MPA 536.6 ± 152.5 300.7 ± 66.9
∆ MAP (mmHg) 19 ± 3 16 ± 4
∆ SBP (mmHg) 22 ± 4 29 ± 8
∆ DBP (mmHg) 18 ± 3 13 ± 3
∆ PP (mmHg) 4 ± 2 16 ± 6
Hypercapnea
∆ HR (bpm) -8 ± 1 -4 ± 1 *
33
∆ PNA amplitude (µV) 8.7 ± 2.7 9.1 ± 1.6
∆ PNA duration (sec) 0.15 ± 0.02 0.11 ± 0.02
∆ PNA frequency (cycles/min) -3 ± 1 -4 ± 1
∆ MPA 178.5 ± 74.08 293.9 ± 71.04
Delta change in phrenic nerve activity (PNA) and blood pressure (mmHg) under 
hypoxic or hypercapnic conditions in adult Lewis and Lewis Polycystic Kidney (LPK) 
rats. MAP: mean arterial pressure, SBP: systolic blood pressure, DBP: diastolic blood 
pressure, PP: pulse pressure; HR: heart rate, MPA: minute phrenic activity. Results are 
expressed as mean ± SEM. *P<0.05 between the Lewis and LPK as determined by 
Student’s t-test. ∆ = Delta change in, n = number of animals per group
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Figures
Figure 1. Representative traces showing higher sympathetic nerve activity during 
different phases of respiration in adult Lewis and LPK rats
Representative data traces showing raw and integrated splanchnic SNA (sSNA and 
∫sSNA), raw and integrated renal SNA (rSNA and ∫rSNA), raw phrenic nerve activity 
(PNA) and raw arterial pressure (AP) in an adult Lewis (A) and LPK rat (B) under 
control conditions. Traces illustrate the higher rSNA, sSNA and AP including pulse 
pressure range in the LPK in comparison to Lewis rats. Expanded trace shows raw and 
integrated splanchnic and renal SNA over two respiratory cycles, noting different scale 
for floating scale bars for Lewis and LPK to allow for clear illustration of respSNA. 
35
Figure 2. Tracings of effect of hypoxia on respiratory-related sympathetic nerve activity 
in adult Lewis and LPK rats.
Example figure illustrating phrenic triggered integrated rSNA (∫rSNA) and sSNA 
(∫sSNA) during different phases of the phrenic cycle (I, inspiration; PI, post inspiration; 
E, expiration within trace of phrenic nerve activity PNA) under control (panels A, B, E, 
F) and hypoxic conditions (panels C, D, G, H) in a Lewis rat (panels A, C, E, G) and 
LPK rat (panels B, D, F, H). 
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Figure 3. Grouped data of effect of hypoxia on respiratory-related sympathetic nerve 
activity in adult Lewis and LPK rats.
Grouped data is shown in panels A-D illustrating the change in peak amplitude (V, 
A/B), and area under the curve ((V.s, AUC; C/D) of the phrenic triggered ∫sSNA 
(panels A/C) and ∫rSNA (panels B/D) under control (SaO2=100%) and hypoxic 
(SaO2=82-84%) conditions. Data is expressed as mean ± SEM n ≥5 per group. * 
represents P<0.05 versus control within each strain, # represents P<0.05 versus 
treatment-matched Lewis.
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Figure 4. Tracings of effect of hypercapnia on respiratory-related sympathetic nerve 
activity in adult Lewis and LPK rats.
Example figure illustrating phrenic triggered integrated rSNA (∫rSNA) and sSNA 
(∫sSNA) during different phases of the phrenic cycle (I, inspiration; PI, post inspiration; 
E, expiration within trace of phrenic nerve activity PNA) under control (panels A, B, E, 
F) and hypercapnic (panels C, D, G, H) conditions in a Lewis rat (panels A, C, E, G) 
and LPK rat (panels B, D, F, H). 
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Figure 5. Group data of effect of hypercapnia on respiratory-related sympathetic nerve 
activity in adult Lewis and LPK rats.
Grouped data is shown in panels A-F illustrating the change in peak amplitude (A/B), 
area under the curve (AUC; C/D) and duration (E/F) of the phrenic triggered ∫sSNA 
(panels A/C/E) and ∫rSNA (panels B/D/F) under control and hypercapnic conditions. 
Data is expressed as mean ± SEM n ≥5 per group. * represents P<0.05 versus control 
within each strain # represents P<0.05 versus treatment-matched Lewis. 
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Figure 6. Effect of stimulation of the peripheral chemoreceptor reflex with NaCN on 
respiratory-related sympathetic nerve activity in juvenile Lewis and LPK rats using the 
working heart brainstem preparation. 
Representative figure illustrating integrated tSNA (∫tSNA) over the respiratory cycle in 
a Lewis rat (panel A) and LPK rat (panel B), noting different floating scale bars for 
Lewis and LPK (∫VNA) to allow for clear illustration of nerve activity. Grouped data 
illustrating effect of peripheral chemoreceptor stimulation on peak amplitude (C) and 
area under the curve (AUC; D) of phrenic triggered ∫tSNA. Data is expressed as mean ± 
SEM n minimum 5 per group. * represents P<0.05 versus control within each strain # 
represents P<0.05 versus treatment-matched Lewis. 
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Figure 7. Effect of stimulation of the central chemoreceptor reflex with hypercapnia on 
respiratory-related sympathetic nerve activity in juvenile Lewis and LPK rats using the 
working heart brainstem preparation. 
Representative figure illustrating phrenic triggered integrated tSNA (∫tSNA) over the 
respiratory cycle in a Lewis rat (panels A and B) and LPK rat (panels C and D) under 
control (panels A and C) and hypercapnic (panels B and D) conditions. Grouped data 
illustrating the effect of central chemoreceptor stimulation on peak amplitude (E) and 
area under the curve (AUC; F) of the phrenic triggered ∫tSNA. Data is expressed as 
mean ± SEM n ≥5 per group. * represents P<0.05 versus control within each strain, # 
represents P<0.05 versus treatment-matched.







1Table 1: Baseline cardiorespiratory function in adult Lewis and LPK rats
Lewis LPK
MAP (mmHg) 90 ± 4 125 ± 10*
SBP (mmHg) 117 ± 8 194 ± 22*
DBP (mmHg) 75 ± 3 99 ± 10*
PP (mmHg) 41 ± 6 87 ± 18*
HR (bpm) 453 ± 9 480 ± 3*
PNA amplitude (µV) 18.3 ± 2.1 24.9 ± 5.3
PNA frequency 
(cycles/min)
36 ± 1 45 ± 1*
PNA duration (s) 0.82 ± 0.1 0.72 ± 0.01
MPA 674.9 ± 86.03 1125 ± 232
sSNA (µV) 3.1 ± 0.5 7.9 ± 1.3*
rSNA (µV) 5.2 ± 0.4 8.9 ± 0.6*
Measures of cardiorespiratory function in Lewis and LPK rats. MAP: mean arterial 
pressure, SBP: systolic blood pressure, DBP: diastolic blood pressure, PP: pulse 
pressure, HR: heart rate, bpm: beats per min, PNA: phrenic nerve amplitude, MPA: 
minute phrenic activity, rSNA: renal sympathetic nerve activity, sSNA: splanchnic 
2sympathetic nerve activity. Results are expressed as mean ± SEM. *P<0.05 between the 
Lewis and LPK as determined by Student’s t-test. n = 9 Lewis and n = 8 LPK excepting 
rSNA where n = 5 LPK and 6 Lewis. 
Table 2: RespSNA parameters in splanchnic and renal sympathetic nerves under 
control conditions. 
Lewis LPK
splanchnic 4.1 ± 0.8 8.8 ± 1.1*
PA (V)
renal 8.7 ± 0.6 11.02 ± 0.8*
splanchnic 0.8 ± 0.07 0.99 ± 0.02Duration 
(sec) renal 0.8 ± 0.05 0.96 ± 0.05
splanchnic 3.5 ± 0.5 8.7 ± 1.1*
AUC (µV.s)
renal 7.1 ± 0.2 10.6 ± 1.1*
Measures of respSNA (phrenic triggered) parameters for integrated sSNA and rSNA in 
Lewis and LPK rats. PA: peak amplitude, AUC: area under curve. Results are expressed 
as mean ± SEM. *P<0.05 between the Lewis and LPK as determined by Student’s t-
test. sSNA data: n = 9 Lewis and n = 8 LPK, excepting rSNA where n = 5 LPK and 6 
Lewis.
1Table 3: Effects of peripheral and central chemoreceptor stimulation on 
cardiorespiratory parameters in adult Lewis and Lewis Polycystic Kidney (LPK) rats
Lewis (n = 9) LPK (n = 8)
∆ MAP (mmHg) 4 ± 4 21 ± 5 *
∆ SBP (mmHg) 5 ± 5 34 ± 11 *
∆ DBP (mmHg) 4 ± 4 16 ± 4 
∆ PP (mmHg) 1 ± 2 18 ± 7 *
∆ HR (bpm) 12 ± 2 10 ± 1 
∆ PNA amplitude (µV) 10.9 ± 3.6 9.8 ± 3.9
∆ PNA duration (sec) 0.13 ± 0.02 0.07 ± 0.01
∆ PNA frequency (cycles/min) 5 ± 2 -2 ± 2*
Hypoxia
∆ MPA 536.6 ± 152.5 300.7 ± 66.9
∆ MAP (mmHg) 19 ± 3 16 ± 4
∆ SBP (mmHg) 22 ± 4 29 ± 8
∆ DBP (mmHg) 18 ± 3 13 ± 3
∆ PP (mmHg) 4 ± 2 16 ± 6
Hypercapnea
∆ HR (bpm) -8 ± 1 -4 ± 1 *
2∆ PNA amplitude (µV) 8.7 ± 2.7 9.1 ± 1.6
∆ PNA duration (sec) 0.15 ± 0.02 0.11 ± 0.02
∆ PNA frequency (cycles/min) -3 ± 1 -4 ± 1
∆ MPA 178.5 ± 74.08 293.9 ± 71.04
Delta change in phrenic nerve activity (PNA) and blood pressure (mmHg) in hypoxia 
(ventilated with only room air) or hypercapnia (ventilated with 5% CO2 with 95% O2) 
when switched from control condition (ventilated with oxygen enriched room air) in 
adult Lewis and Lewis Polycystic Kidney (LPK) rats under urethane anaesthesia. MAP: 
mean arterial pressure, SBP: systolic blood pressure, DBP: diastolic blood pressure, PP: 
pulse pressure; HR: heart rate, MPA: minute phrenic activity. Results are expressed as 
mean ± SEM. *P<0.05 between the Lewis and LPK as determined by Student’s t-test. ∆ 
= Delta change in, n = number of animals per group
